PTIX Protagenic: Quarterly EPS earnings growth
Protagenic Therapeutics (PTIX) is building a neurobiology foundation by combining the study of TCAP hormones with the treatment of anxiety disorders, although a lack of sales deprives the company of pricing power. The quarterly EPS growth marker helps filter out market noise and identify a fundamental bottom, with 76.10 serving as the current value of this metric. Investments carry high risks due to early-stage trials and a dependence on venture capital.
%20Net%20earnings%20per%20share%20growth%20for%20the%20trailing%20year&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_PTIX_-_Protagenic-Therapeutics_-_Net-earnings-per-share-growth-for-the-trailing-year "Quarterly EPS earnings growth: Protagenic (PTIX) for 07/04/2022 - 01/10/2026 | 👁️GURU.Markets👁️")
Summary analytical data breakdowns for Protagenic Therapeutics (PTIX)
- share price and expert price forecast:
- company stock capitalization data:
- balance sheet net asset value indicators:
- issuer credit burden and liquidity indicators:
Total Debt to Capital Protagenic Therapeutics|PTIX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital protagenic.com|PTIX - Company Total Debt|Debt to Book Value Protagenic|PTIX - Company Long-Term Loans and Borrowings|Company Current Liabilities Protagenic Therapeutics|Quick Ratio protagenic.com
- earnings and valuation multiples indicators:
PTIX - Final Profit|Projected Future Earnings Protagenic Therapeutics|PTIX - Market Cap to Earnings|Future Price to Earnings protagenic.com|PTIX - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Protagenic|PTIX - Operating profit EBITDA|Earnings per share for the last twelve months Protagenic Therapeutics|PTIX - Earnings per one share for the last 12 months|Quarterly EPS earnings growth protagenic.com|PTIX - Earnings per share growth rate in current year|Expected earnings per share growth for next year Protagenic Therapeutics
- sales volume and revenue indicators:
Basic company analysis:Protagenic Therapeutics Inc., PTIX
To assess the financial stability of Protagenic Therapeutics (PTIX), tracking the dynamics of net earnings per share is critically important. This quarterly EPS growth index measures the percentage change in earnings between reporting periods, which for a peptide R&D company reflects the efficiency of expense management prior to the monetization of patents through royalties, signaling the business's transition toward scalability.
Who Protagenic Therapeutics competes with
BIIB: Quarterly EPS earnings growth|Neurocrine (NBIX) - Quarterly EPS earnings growth|RGC (Regencell) - Quarterly EPS earnings growth|AXSM - Net earnings per share growth for the trailing year|Quarterly EPS earnings growth ACAD|XENE - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Viking Therapeutics, Inc. VKTX|SUPN: Year-over-year earnings per share growth for the last 12 months|Catalyst Pharmaceuticals Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Denali Corp DNLI|HRMY: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months biohavenpharma.com|Year-over-year net earnings per share growth for the last 12 months AMLX|TRVI: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months PRAX (Praxis Medicines)|Year-over-year earnings per share growth rate for the last twelve months AVXL|Quarterly EPS earnings growth CBLL (CeriBell, Inc.)|Year-over-year earnings per one share growth for the last 12 months PRTA|Alector Therapeutics - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Annexon Biosciences|omeros.com (OMER) - Year-over-year earnings per share growth for the last twelve months|Neurogene Therapeutics - Year-over-year earnings per one share growth for the last 12 months|ACIU (AC Immune) - Quarterly EPS earnings growth|Quarterly EPS earnings growth voyagertherapeutics.com|Year-over-year earnings per share growth for the last twelve months Neumora Therapeutics, Inc. (NMRA)|SCLX: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth TVGN (Tevogen Bio Holdings, Inc.)|Alpha Cognition Inc (ACOG) - Earnings per share growth in annualized terms for the last twelve months|CGTX: Year-over-year net earnings per share growth for the last 12 months|IKT - Quarterly EPS earnings growth|SAVA (Cassava Sciences) - Year-over-year net earnings per share growth for the last 12 months|ASRT: Year-over-year earnings per share growth rate for the last twelve months|COYA (Coya Therapeutics Inc) - Quarterly EPS earnings growth|VistaGen Therapeutics Inc (VTGN) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth OVID|Year-over-year net earnings per share growth for the last 12 months acumenpharm.com ABOS|Year-over-year earnings per share growth for the last twelve months CervoMed CRVO|Year-over-year net earnings per share change for the last twelve months Alterity Therapeutics Ltd. (ATHE)|CLNN - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months PEPG|JUNS (Jupiter Neurosciences) - Year-over-year net earnings per share growth for the last 12 months|RLMD: Year-over-year earnings per share growth rate for the last twelve months|ANVS (Annovis Bio) - Quarterly EPS earnings growth|Grace Tx (GRCE) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months AIFF (Firefly Neuroscience Inc)|anewmeds.com - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months NeuroSense Therapeutics Ltd. NRSN|RVPH: Year-over-year earnings per share growth for the last 12 months|MetaVia, Inc. - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months NeurAxis Inc.|HSDT (heliusmedical.com) - Year-over-year net earnings per share growth for the last 12 months|Passage Bio (PASG) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Neuphoria Therapeutics, Inc.|NERV: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Athira Pharma (ATHA)|ADXN - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Alzamend Neuro ALZN|CYCN (Cyclerion Therapeutics Inc.) - Year-over-year net earnings per share trend for the last twelve months|KTTA - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months CRGT (Cortigent, Inc.)|Avenue Therapeutics, Inc. (ATXI) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Brainstorm Cell Therapeutics Inc. (BCLI)|Year-over-year net earnings per share growth for the last 12 months CARA|CHRO (Chromocell) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth ELYM|Quarterly EPS earnings growth intracellulartherapies.com (ITCI)|Quarterly EPS earnings growth LBPH (Longboard Pharmaceuticals, Inc.)|Net earnings per share growth for the trailing year Marinus Pharmaceuticals Inc|NKGen - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months NeuroBo Pharma|Sage Therapeutics, Inc. (SAGE) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months SNPX|TRVN (Trevena) - Quarterly EPS earnings growth|Vigil Neuro (VIGL) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth WENA|Year-over-year net earnings per share growth for the last 12 months Cerevel Corp CERE
